179 related articles for article (PubMed ID: 15963205)
1. Anticardiolipin antibody and Taiwanese chronic haemodialysis patients with recurrent vascular access thrombosis.
Chuang FR; Chang HW; Lin CL; Wang IK; Chang HY; Wang PH; Yang CC; Chen TC; Wu CS; Lee CH
Int J Clin Pract; 2005 Jul; 59(7):785-90. PubMed ID: 15963205
[TBL] [Abstract][Full Text] [Related]
2. Anticardiolipin antibodies and vascular access thrombosis in Taiwanese haemodialysis patients with chronic hepatitis C: a retrospective study.
Lee CH; Wang IK; Chen TC; Chang HW; Yang CC; Chien YS; Wu CS; Chiou TT; Wu MS; Wang PH; Chuang FR
Int J Clin Pract; 2006 Dec; 60(12):1591-5. PubMed ID: 16704678
[TBL] [Abstract][Full Text] [Related]
3. IgM-anticardiolipin antibody and vascular access thrombosis in chronic hemodialysis patients.
Chuang FR; Chen TC; Yang CC; Cheng YF; Hsu KT; Lee CH; Lin CL; Wang IK; Chang HW; Wang PH
Ren Fail; 2005; 27(1):25-30. PubMed ID: 15717631
[TBL] [Abstract][Full Text] [Related]
4. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.
Adler S; Szczech L; Qureshi A; Bollu R; Thomas-John R
Clin Nephrol; 2001 Dec; 56(6):428-34. PubMed ID: 11770794
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinaemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: a retrospective study.
Chen TC; Wang IK; Lee CH; Chang HW; Chiou TT; Lee CT; Fang JT; Wu MS; Hsu KT; Yang CC; Wang PH; Chuang FR
Int J Clin Pract; 2006 Dec; 60(12):1596-9. PubMed ID: 16704682
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine and vascular access thrombosis in end-stage renal disease patients: a retrospective study.
Bowden RG; Wyatt FB; Wilson R
J Nephrol; 2002; 15(6):666-70. PubMed ID: 12495281
[TBL] [Abstract][Full Text] [Related]
7. Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure.
Ozmen S; Danis R; Akin D; Batun S
Clin Nephrol; 2009 Sep; 72(3):193-8. PubMed ID: 19761724
[TBL] [Abstract][Full Text] [Related]
8. The association between pulse pressure and vascular access thrombosis in chronic hemodialysis patients.
Chou CY; Liu JH; Kuo HL; Liu YL; Lin HH; Yang YF; Wang SM; Huang CC
Hypertens Res; 2009 Aug; 32(8):712-5. PubMed ID: 19590503
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW
Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142
[TBL] [Abstract][Full Text] [Related]
10. Anticardiolipin antibodies in children on chronic haemodialysis.
Sallam S; Wafa E; el-Gayar A; Sobh M; Salama O
Nephrol Dial Transplant; 1994; 9(9):1292-4. PubMed ID: 7816292
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis E virus (HEV) infection in haemodialysis patients. The Multicentre Haemodialysis Cohort Study on Viral Hepatitis.
Psichogiou M; Vaindirli E; Tzala E; Voudiclari S; Boletis J; Vosnidis G; Moutafis S; Skoutelis G; Hadjiconstantinou V; Troonen H; Hatzakis A
Nephrol Dial Transplant; 1996 Jun; 11(6):1093-5. PubMed ID: 8671974
[TBL] [Abstract][Full Text] [Related]
12. Effect of 1-year oral alpha-tocopherol administration on anticardiolipin antibodies in hemodialysis patients.
Antoniadi G; Eleftheriadis T; Liakopoulos V; Kakasi E; Vayonas G; Kortsaris A; Vargemezis V
Ren Fail; 2005; 27(2):193-8. PubMed ID: 15807185
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis C viral in patients with terminal chronic kidney failure. I. Prevalence].
González-Michaca L; Mercado A; Gamba G
Rev Invest Clin; 2000; 52(3):246-54. PubMed ID: 10953607
[TBL] [Abstract][Full Text] [Related]
14. Predictors of vascular access thrombosis among patients on the cadaveric renal transplantation waiting list.
Akman B; Afsar B; Ataç FB; Ibis A; Arat Z; Sezer S; Ozdemir FN; Haberal M
Transplant Proc; 2006 Mar; 38(2):413-5. PubMed ID: 16549134
[TBL] [Abstract][Full Text] [Related]
15. A large prospective survey of anti-cardiolipin antibodies in chronic hemodialysis patients.
Valeri A; Joseph R; Radhakrishnan J
Clin Nephrol; 1999 Feb; 51(2):116-21. PubMed ID: 10069647
[TBL] [Abstract][Full Text] [Related]
16. Anticardiolipin antibody isotype profile in lupus nephritis--a cross sectional survey.
Azizah MR; Loo CS; Zulkifli MN; Shahnaz M; Zaki M; Nasuruddin BA
Med J Malaysia; 1998 Sep; 53(3):257-62. PubMed ID: 10968163
[TBL] [Abstract][Full Text] [Related]
17. Anti-cardiolipin, anti-endothelial-cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis: relationship with vascular access thrombosis and thromboembolic events.
George J; Aron A; Levy Y; Gilburd B; Ben-David A; Renaudineau Y; Zonana-Nachach A; Youinou P; Harats D; Shoenfeld Y
Hum Antibodies; 1999; 9(2):125-31. PubMed ID: 10405833
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of anticardiolipin antibodies in chronic hepatitis B infection together with total anti-delta positivity].
Meşe S; Ozekinci T; Atmaca S; Arikan E; Akin D
Mikrobiyol Bul; 2008 Jul; 42(3):483-7. PubMed ID: 18822893
[TBL] [Abstract][Full Text] [Related]
19. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis.
Prakash R; Miller CC; Suki WN
Am J Kidney Dis; 1995 Aug; 26(2):347-52. PubMed ID: 7645540
[TBL] [Abstract][Full Text] [Related]
20. Anticardiolipin IgG antibody and homocysteine as possible risk factors for retinal vascular occlusive disease in thai patients.
Atchaneeyasakul LO; Trinavarat A; Bumrungsuk P; Wongsawad W
Jpn J Ophthalmol; 2005; 49(3):211-5. PubMed ID: 15944825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
